1. Introduction {#sec1}
===============

Pacific oysters *(Crassostrea gigas)* make the greatest contribution to global oyster production with 625,925 tonnes per annum worth US\$ 1.3 billion out of a total oyster production of 5.2 million tonnes worth US\$ 4.2 billion ([@bib19]). In Australia, edible oyster farming contributes approximately 38% to the total marine mollusc production, with an estimated 11.3 thousand tonnes produced in 2015--2016 ([@bib55]). However, outbreaks of severe and widespread oyster mortality have greatly impacted Pacific oyster farming in Australia ([@bib34]; [@bib62]; [@bib11]), New Zealand ([@bib36]) and in Europe ([@bib82]; [@bib23]; [@bib63]; [@bib77]; [@bib7]).

Outbreaks of summer mortalities in Pacific oysters were first reported in Japan in 1950 ([@bib85]) and since then this syndrome affecting adult oysters was reported in many parts of the world, including Italy ([@bib85]), USA ([@bib26]) and France ([@bib54]). In France, mass mortality events have also been reported in *C. gigas* spats since 1993 ([@bib71]), which were later identified to be associated with *Ostreid herpesvirus-1* (OsHV-1) ([@bib10]; [@bib23]). The reference genotype of OsHV-1 ([@bib43]; [@bib10]) and related genotypes have been identified as the prominent pathogens which caused *C. gigas* mortalities in France from 1991 to 2008 ([@bib53]; [@bib75]). However, at the end of spring 2008, widespread mortalities were reported in France which killed billions of young oysters and a genomic variant of OsHV-1, called μVar, was identified from these outbreaks ([@bib82]; [@bib75]). Since then, severe disease of Pacific oysters associated with the variant and closely related microvariant genotypes were associated with disease events observed in different parts of the world, including Australia ([@bib34]; [@bib61]; [@bib93]), New Zealand ([@bib75]), Ireland ([@bib63]; [@bib7]), Spain ([@bib77]) and Scandinavia ([@bib56]).

Despite the different genotypes of OsHV-1 and their causal relationship with oyster mortality, Pacific oyster mortality events are most often considered a result of complex interactions between the physiological status of the oysters, the environment and multiple pathogens ([@bib78]; [@bib1]; [@bib66]; [@bib12]). Considering the age of oysters, spat and juvenile oysters are generally more susceptible to OsHV-1 infection and related mortality events ([@bib72]; [@bib80]), while processes such as spawning which causes physiological stress also predispose oysters to mortality ([@bib78]; [@bib23]). Furthermore, research has revealed a role of oyster genotype in susceptibility to the viral infections and mortality events ([@bib13]; [@bib3]; [@bib12]). Meanwhile, environmental factors such as elevated seawater temperature ([@bib67]; [@bib74]), alterations in salinity ([@bib84]; [@bib22]) and pH of water ([@bib21]) have also been reported to affect the outcome of OsHV-1 infections.

Reinforcing the complex interactions between oysters, the environment and pathogen factors, it is notable that microvariant genotypes of OsHV-1 can be present in Pacific oysters without associated mortality ([@bib15]; [@bib83]; [@bib32]). Not all host and environmental factors that contribute to the pathogenesis related to infectious processes and subsequent oyster mortality are clearly understood. The role of bacteria in summer mortality of oysters was questioned after demonstration of high loads of *Vibrio* spp. in the haemolymph of moribund oysters ([@bib47]). Several subsequent studies report isolation/detection of pathogenic *Vibrio* spp. from Pacific oysters during mass mortality outbreaks such as *Vibrio splendidus* ([@bib40]; [@bib45]; [@bib65]), *Vibrio aestuarianus* ([@bib24]) and *Vibrio harveyi* ([@bib79]). Recently, Pacific oysters exposed to a mass mortality outbreak and subsequently treated with antibiotics demonstrated delayed and reduced mortality compared to oysters that were not treated with antibiotics ([@bib69]). The suggestion of a role for bacteria present in the oyster microbiome or environment in the pathogenesis was supported by a rapid increase in the cultivable *Vibrio* count preceding OsHV-1 replication in the same outbreak ([@bib69]). Recently, [@bib12] demonstrated that infections caused by the variant μVar result in immunosuppression which shifts the oyster microbiome to allow opportunistic infections from bacteria such as *Vibrio.*

The Pacific oyster microbiome is dominated by *Proteobacteria* ([@bib31]; [@bib20]; [@bib88]). The results of recent 16S rRNA gene studies suggest that *Pseudomonas* and *Vibrio* are not abundant members of the oyster microbiome ([@bib88]; [@bib49]; [@bib37]). Instead, members of the phylum *Bacteroidetes,* phylum *Firmicutes* ([@bib88]) and *Arcobacter* spp. ([@bib20]) have been shown to be abundant in the oyster microbiome. The microbiome composition can be influenced by oyster genetics ([@bib91]) and can change under various conditions that cause stress in oysters, including temperature ([@bib49]), translocation ([@bib50]), infection ([@bib28]) and antibiotic stress ([@bib51]). The immediate environment can influence the microbiome composition of oysters, owing in part to their filter-feeding ([@bib44]; [@bib50]). During times of stress, many of the environmental bacteria that are taken in may opportunistically colonize the oyster ([@bib28]).

It is interesting to investigate how the microbiome composition of Pacific oysters with a common genetic background is affected by the environment they live in, and whether alterations in the microbiome can contribute to a differential response to the infection caused by OsHV-1. The aim of the current study was to evaluate changes in the Pacific oyster microbiome with changes in their environment and during progression of an experimental OsHV-1 infection. Specifically, studies were conducted to: (1) assess differences in the bacterial communities in Pacific oysters with a common origin but grown in three geographically distinct estuaries; (2) to evaluate changes occurring in the microbiota, with special reference to *Vibrio* populations and in response to OsHV-1 infection; and (3) to evaluate the responses of different batches of oysters with distinctly different life history, to an experimental OsHV-1 infection, conducted in a controlled laboratory environment.

2. Materials & methods {#sec2}
======================

2.1. Oysters and their husbandry {#sec2.1}
--------------------------------

Healthy triploid Pacific oysters (n = 348; 30--80 mm shell length) sourced from a commercial hatchery (Shellfish Culture Ltd., Tasmania) were used in this study. Different batches were grown under commercial farming conditions for 7 months in Patonga Creek, Hawkesbury River (juveniles, 10 months old, n = 116), or for 11--12 months in Shoalhaven River (adults, 14 months old, Goodnight Oysters, Greenwell Point, n = 116) or the Clyde River (adults, 16 months old, Signature Oysters, n = 116). These are 3 geographically separated estuaries in NSW, Australia which are impacted by a variety of human activities in addition to oyster farming. None of these oysters had been previously exposed to OsHV-1 based on surveillance for freedom from OsHV-1 in these estuaries and all oysters were certified negative for OsHV-1 by the competent government authority at the time of interstate transport from the hatchery to NSW. Further, the oysters were confirmed negative by testing a sample (n = 12) of each batch using a real-time quantitative PCR (qPCR) assay. The oysters were transported to a physical containment level 2 aquatic facility at the University of Sydney and acclimated for 3 days before experimental infection.

The oysters from each batch were randomly allocated to eight replicate 15 L tanks (n = 14 oysters per tank), making 24 tanks in total. A static water system was maintained with aerated, artificial seawater (ASW; Red Sea® salt, 30--31 ppt salinity) at 22 °C. Six of the tanks for each batch were designated for challenge with OsHV-1 while 2 tanks were designated for oysters challenged with the negative control.

Temperature data-loggers (Thermocron®) recorded the temperature every 30 min in selected tanks. The pH of water was maintained at 8.2 (range: 8.0--8.2) and ammonia, nitrite and nitrate levels were maintained \<0.25 ppm. These water quality parameters were monitored daily, and adjustments were performed as required, by water exchange. Oysters were fed with a maintenance ration of commercial algae diet (Shellfish Diet, 1800; Reed Mariculture) daily in the morning. Mortality was recorded with twice daily monitoring for 7 days. Dead oysters were removed and stored at −80 °C until molecular studies were conducted.

2.2. Source of infective OsHV-1 {#sec2.2}
-------------------------------

A cryopreserved, filtered oyster tissue homogenate with confirmed OsHV-1 infection was used as the inoculum. The tissue homogenate was stored as multiple aliquots, at -80 °C with 10% v/w fetal bovine serum (Gibco) and 10% v/v glycerol. The inoculum was prepared from diseased oysters from a previous OsHV-1 related mortality event and had been used in previous experimental infections ([@bib61]). The negative control was prepared as a cryopreserved, filtered tissue homogenate prepared from apparently healthy Pacific oysters from a disease-free population ([@bib18]). The cryopreserved inoculums were thawed at 4 °C and diluted by 1:100 in distilled water (Ultrapure™) to provide the dose described below.

2.3. Challenge with OsHV-1 {#sec2.3}
--------------------------

Oysters were immersed in a solution of MgCl~2~ (50 g/l) for 4--6h until relaxation of the adductor muscles caused the valve to open. A 100 μl aliquot of the diluted OsHV-1 inoculum (6.5 × 10^5^ OsHV-1 DNA copies μl^−1^) was injected into the adductor muscle, using a 1 ml syringe and a 25-gauge needle. The control oysters were injected with a diluted, filtered oyster tissue homogenate that was negative for OsHV-1. After injection, oysters were transferred to the same designated tanks without feed for 8 hours. Physical separation and procedural care were taken to prevent cross contamination between tanks.

2.4. Sampling {#sec2.4}
-------------

Twelve oysters (n = 4 from each batch) were sampled on Day 0 prior to injection. Thereafter, 2 live oysters per tank were sampled on Days 1, 2, 3, 5 and 7. Samples were maintained on ice until processing. Dead oysters were sampled if identified by non-responsive gaping when exposed to external stimuli including air exposure.

2.5. OsHV-1 DNA quantification {#sec2.5}
------------------------------

Oysters were carefully shucked and equal portions of gill and mantle tissue (0.08--0.12 g total) were excised and placed in a 1.5 ml tube containing 1 ml of distilled water (Ultrapure™) and 0.4 g of 0.1 mm zirconia-silica beads (Biospec Products, Daintree Scientific). The tubes were kept at -80 °C until homogenization by bead-beating with a TissueLyser II (Qiagen) at a frequency of 30 Hz for 2 × 2 min cycles with 180° rotation of the tubes. The tubes were then centrifuged at 900 *g* for 10 min and 50 μl of the supernatant was used for nucleic acid extraction.

Nucleic acids were purified from 50 μl of clarified gill and mantle homogenates using the MagMax™-96 Viral RNA Isolation Kit (Thermo Fisher Scientific) with a BioSprint-96 ™ magnetic particle processor (Qiagen) using the AM1836 deep-well standard program (Thermo Fisher Scientific). Purified nucleic acids were eluted in 75 μl elution buffer and were stored at -20 °C until OsHV-1 quantification.

The number of copies of the B-region of the OsHV-1 genome was determined relative to a plasmid DNA standard according to a method described by [@bib60], adapted from a qPCR assay using hydrolysis probe chemistry ([@bib52]). Samples were tested in duplicate 25 μL reactions prepared with Path-ID qPCR master mix (Life Technologies), the primers OsHV1BF and OsHV1B4 and the fluorescent probe, OsHV1ProbeB ([Table 1](#tbl1){ref-type="table"}) and tested using a Mx3000P Multiplex Quantitative PCR System (Stratagene).Table 1Primers and probes used in this study.Table 1Code of primer/probeSequence (5'→3′)ReferenceOsHV1BF5′- GTCGCATCTTTGGATTTAACAA-3′[@bib52]OsHV1B45′-ACTGGGATCCGACTGACA AC-3′[@bib52]OsHV1ProbeB5′-6FAM-TGCCCCTGTCATCTTGAGGTATAGACAATC-TAMRA-3′[@bib52]Vib15′-GGCGTAAAGCGCATGCAGGT-3′[@bib90]Vib25′-GAAATT CTACCCCCCTCTACAG-3′[@bib90]Nadak_rRNAF5′-TCCTACGGGAGGCAGCAGT-3′[@bib57]Nadak_rRNAR5′-GGACTACCAGGGTATCTAATCCTGTT-3′[@bib57]Nadak_rRNA probe5′-6FAM-CGTATTACCGCGGCTGCTGGCAC-BHQ1-3′[@bib57]27F5′-AGAGTTTGATCMTGGCTCAG-3′[@bib41]519R5′-GWATTACCGCGGCKGCTG-3′[@bib41]1492R5′-TACCTTGTTACGACTT-3′[@bib92]

2.6. Bacterial studies {#sec2.6}
----------------------

Each sample was prepared from soft tissues remaining after the gill and mantle biopsy and after removal of the digestive gland. The tissues were transferred into a pre-weighed stomacher bag (Interscience, France), weighed and disrupted by stomaching with 4× (w/v) sterile ASW, in a bag mixer (MiniMix, Interscience, France) for 1 min, at maximum (9) speed. On Day 0, individual oysters were homogenized and thereafter, tissues from 4 oysters from each treatment and the same batch were pooled and homogenized. A coarsely clarified homogenate (5 ml) was obtained by collecting the material filtered through the inner mesh (porosity \<250 μm) of the stomaching bag (BagPage®, Interscience, France). These homogenates were used directly for bacterial culture and stored at -80 °C for molecular studies of bacterial content.

Preparation of homogenates for bacterial molecular studies was by bead beating as previously described, with 150 μl of homogenates, 390 μl lysis/binding solution (MagMax™ - 96 Viral RNA Isolation Kit) in a 2 ml microcentrifuge tube containing 0.4 g of silica-zirconia beads. Homogenates were centrifuged at 900 *g* for 10 min and 180 μl of the supernatant was used for the nucleic acid purification with the MagMax™-96 Viral Isolation Kit. Nucleic acids were stored at -20 °C until bacterial DNA quantification.

### 2.6.1. Isolation, identification and quantification of cultivable vibrio and total bacteria {#sec2.6.1}

Ten microliters each from each fresh tissue homogenate was spread on a marine salt agar-blood (MSA-B) plate and a thiosulphate-citrate-bile salts-sucrose (TCBS) agar (Oxoid, UK) plate separately, using sterile disposable spreaders (Copan, Brescia, Italy). MSA-B was made using 20 g of BD® tryptone soy agar, 7.5 g NaCl, 500 ml of deionized, ultrapure water and 15 ml of sterile, anticoagulated, sheep blood for each 500 ml of MSA-B ([@bib5]). The inoculated culture plates were incubated at 23 °C for 24h (MSA-B) or 48hr (TCBS agar) in a refrigerated incubator (LMS Ltd, UK).

Bacterial colonies on MSA-B plates and TCBS plates were counted and the number of colony forming units (CFU)/g of oyster tissue were calculated (total cultivable bacterial count, TCBC; total cultivable *Vibrio* count, TCVC). Colony morphology on TCBS plates was recorded based on visual assessment of size and colour. Single colonies of dominant morphotypes on TCBS agar were directly inoculated into nutrient broth with 2% NaCl and incubated at 23 °C overnight. Broth cultures (0.85 ml) were mixed with glycerol (0.15 ml) and stored at -80 °C. Species identification of select cryopreserved *Vibrio* cultures was later performed at the Animal Health Laboratories, Department of Agriculture, Western Australia, using biochemical methods.

### 2.6.2. Quantification of total vibrio spp. DNA by qPCR {#sec2.6.2}

The qPCR assay described by [@bib90] was adapted for quantification of *Vibrio* spp. The primers Vib1 and Vib2 ([Table 1](#tbl1){ref-type="table"}) amplify a target between position 567 and 680 (based on the *Escherichia coli* numbering system) of the 16S ribosomal RNA gene which is specific for the genus *Vibrio* \[[@bib90]; [@bib86]\].

Samples were tested in duplicate 20 μl reactions prepared with Fast SYBR® Green Master Mix (Applied Biosystems), using a 7500 Fast RT-PCR system (Applied Biosystems, Foster City, CA). Each reaction contained 10 μl of Fast SYBR® Green Master Mix (2x), 0.2 μM of each primer, 5 μl of neat template DNA and sterile, nuclease free water. The thermocycling programme was: initial denaturation at 95 °C for 20 s; 40 cycles of denaturation at 95 °C for 3 s and annealing at 58 °C for 30 s; melt curves of the final PCR products were generated and automatically analysed from 60 °C to 95 °C at 1 °C intervals.

Quantitative standards and positive control samples were prepared from genomic DNA of *Vibrio alginolyticus* isolated from oysters used in this study. The *Vibrio* gene copy numbers in the standards were estimated by determining the CFU/ml in *V. alginolyticus* cultures at stationary phase. A spread plate method enumerated colonies by spreading serial dilutions of the *V. alginolyticus* broth culture on TCBS agar plates ([@bib4]; [@bib30]). Each of 6 ten-fold dilutions was spread on three replicate plates. The total *Vibrio* count per PCR sample was calculated by dividing the total *Vibrio* 16S rDNA copy number by the presumptive number of 16S rDNA copies per *Vibrio* genome \[n = 9 ([@bib38]; [@bib86]; [@bib90]),\]. The total *Vibrio* count per oyster tissue homogenate was expressed as number of *Vibrio* genome equivalents per mg of oyster tissue.

Quantification of *Vibrio* spp. DNA in samples was determined by standard curve quantitation method, using 7500 software v2.3 (Applied Biosystems) for a 10-fold serial dilution containing between 4.65 × 10^1^ and 4.65 × 10^6^ copies of *Vibrio* rRNA gene. A PCR run was considered valid when there was no amplification of no template controls; amplification of both replicates of the positive control with a cycle threshold (Ct) within the range of the standard curve; and standard curve with r^2^ \> 0.99 and efficiency between 90 and 110%. Samples exhibiting an exponential increase in SYBR fluorescence signal in both replicates with a C~t~ value \> 15 and \<35 and a dissociation curve (T~m~ ranging from 77.7 to 79.1 °C) that conformed to that of the positive control, were considered for quantification of total *Vibrio* DNA.

### 2.6.3. Quantification of total bacterial DNA by qPCR {#sec2.6.3}

The qPCR assay based on TaqMan® chemistry described by [@bib57] was used to quantify total bacteria. The primers Nadak_rRNAF and Nadak_rRNAR and probe, Nadak_rRNA ([Table 1](#tbl1){ref-type="table"}) target position 331 to 797 of 16S rRNA gene (*Escherichia coli* numbering system) which is highly conserved across domain *Bacteria.*

Purified nucleic acids were tested in duplicate 25 μl PCR reactions prepared in TaqMan™ Fast Universal PCR Master Mix (2×) (Thermofisher Scientific), using Fast 7500 Real-time PCR system (Applied Biosystems). Each reaction contained 12.5 μl of 2× Master Mix, 0.9 μM of each primer and 0.1 μM probe, 5 μl of neat template DNA and sterile, nuclease free water. The thermocycling program was: initial denaturation of 95 °C for 10 min; 40 cycles of denaturation at 95 °C for 15 s, and annealing at 60 °C for 1 min.

The standard was prepared from nucleic acids purified from a non-pathogenic *Escherichia coli* strain 2038 culture that was quantified by spread plate method. Gene copy numbers were estimated from CFU/ml in *E. coli* culture. PCR runs were analyzed by the standard curve quantitation method (Applied Biosytems) based on amplification of a 10-fold serial dilution containing between 1.84 × 10^1^ and 1.84 × 10^8^ copies of *E. coli* rRNA gene. A PCR run was considered valid when there was no amplification of negative controls; amplification of both replicates of the positive control with a cycle threshold (Ct) within the range of the standard curve; and standard curve with r^2^ \> 0.99 and efficiency between 90 and 110%. Samples exhibiting an exponential increase in the fluorescence signal in both replicates with a C~t~ value \> 15 and \<35, were considered for quantification of the total bacteria DNA. Total bacteria quantity of samples was expressed as the number of bacteria genome equivalents per mg oyster tissue. This was calculated by dividing the total 16S rDNA gene copies by the presumptive number of 16S rDNA copies per *Proteobacteria* genome \[n = 3.5, [@bib39]; [@bib90]\], based on the species of bacteria of the phyla that dominate the oyster microbiota ([@bib70]; [@bib91]; [@bib50]).

2.7. Microbiome analysis by high throughput 16S rRNA gene sequencing {#sec2.7}
--------------------------------------------------------------------

The microbial community composition was identified by high-throughput sequencing (MiSeq, Illumina) of the hypervariable region V1--V3 of the 16S rRNA gene. Twenty-six nucleic acid extracts were selected for analysis, to represent 5 different OsHV-1 infection and disease states for each of the 3 batches of oysters ([Table 2](#tbl2){ref-type="table"}).Table 2Cohorts of oysters used for microbiome analysis (On average, n = 8 oysters were evaluated per batch/cohort).Table 2CohortDescriptionAPacific oysters before OsHV-1 challengeBApparently healthy oysters soon after OsHV-1 challengeCChallenged oysters at or near deathDSurviving oysters at the completion of a 7-day OsHV-1 challenge periodEUnchallenged control oysters at the end of a 7-day trial period

Initially, the V1--V8 hypervariable region of the 16S rRNA gene was amplified using the primers 27F and 1492R \[[Table 1](#tbl1){ref-type="table"} ([@bib92]);\]. Reactions were prepared with the Expand High Fidelity PCR System (Roche®, Germany) and used a BioRad T100™ thermal cycler (Applied Biosystems). The PCR amplification was carried out in two stages to overcome inhibition and minimize the impact of PCR bias on diversity profiling. The first stage of amplification was carried out with 8 replicates per nucleic acid sample in a 50 μl reaction containing 200 μM of each dNTP, 0.3 μM of each primer, 5 μl of template DNA, 0.75 μl of Expand High Fidelity enzyme mix, 5 μl of Expand High Fidelity buffer (10x, 15mM MgCl~2~) and sterile, nuclease free water. The PCR program was: initial denaturation of 95 °C for 5 min; 30 cycles of denaturation at 94 °C for 15 s, annealing at 50 °C for 30 s and elongation at 72 °C for 1 min; final elongation of 72 °C for 7 min. Replicate PCR products were pooled, mixed by vortexing and 5 μl from the amplicon pool was used as template in stage 2 amplification using the same PCR conditions. Products were visualised by gel electrophoresis using 2% agarose gels containing RedSafe (Intron, Biotechnology).

Appropriate size PCR products were purified using the QIAamp DNA minikit (Qiagen) and submitted to the Australian Genome Research Facility (AGRF). PCR amplicons generated using primers 27F ([@bib41]) and 519R ([@bib42]; [Table 1](#tbl1){ref-type="table"}), using AmpliTaq Gold 360 Master mix (Life Technologies, Australia). Indexing the amplicons was performed with TaKaRa Taq DNA Polymerase (Clontech) and the resulting amplicons were measured by fluorometry (Invitrogen™ Picogreen) and normalised to provide an equimolar pool of amplicons. These were quantified by qPCR and sequenced with Illumina MiSeq 300bp paired end chemistry.

### 2.7.1. Bioinformatic analyses {#sec2.7.1}

Paired-ends reads were assembled by aligning the forward and reverse reads using PEAR v0.9.5 ([@bib94]), primer sequences were trimmed and USEARCH ver. 8.0.1623 ([@bib16]; [@bib17]) was used for quality filtering and to remove full-length duplicate sequences and singletons. Chimeric sequences were detected against the reference database (RDP Gold database) and discarded. Sequences were clustered into operational taxonomic units (OTUs) at 97% similarity and taxonomy was assigned using the RDP classifier ([@bib48]) as implemented in QIIME, against the Greengenes database ver. 13_8 (Aug 2013) ([@bib14]). An OTU table was generated by calculating the absolute abundance of each identified OTU for each sample, based on the number of sequenced reads. OTUs with an abundance of less than 10 reads per sample were discarded.

2.8. Data analyses {#sec2.8}
------------------

Survival analyses were conducted using the Kaplan-Meier estimate ([@bib35]), notwithstanding an experiment design focused on longitudinal sampling. Oysters collected during random sampling and surviving oysters at the end of the experiment were censored at the respective observation time. Survival time was measured as days from the onset of the injection when oysters were injected with the OsHV-1 inoculum. Each batch of oysters was compared using a mixed Cox regression model ([@bib9]), taking into account the random effect of tank, using RStudio ver. 3.4.4 (R Core Team, 2018). The proportionality of hazards (PH) was checked based on Schoenfeld residuals ([@bib81]).

The OsHV-1 DNA quantity, total bacteria, total *Vibrio*, TCBC and TCVC in oysters were compared between batches, between live and dead oysters of the same batch, between days after OsHV-1 challenge in a batch and with relevant control groups. Data were log~10~ transformed for normal distribution. Kruskal-Wallis test was used for OsHV-1 data analysis and the analyses of bacterial data in oysters before OsHV-1 challenge. The bacterial data (total bacteria, total *Vibrio*, TCBC and TCVC) in oysters during the viral challenge period were done using separate generalized linear models (GzLM, SPSS Statistics ver. 22; IBM SPSS Cooperation, Somers, NY, USA). The main effects of batch including the geographic origin of oysters (Patonga Creek, Shoalhaven River, Clyde River), treatment (OsHV-1 injected or negative control), outcome of infection (live or dead) and the days post-injection (Day 1, 2, 3, 5 and 7) were tested together with possible interactions. Post-hoc pairwise mean comparisons were made using the least significant difference method. The results were presented as geometric means and their corresponding 95% confidence intervals of OsHV-1 genome equivalents, bacterial genome equivalents or *Vibrio* genome equivalents/mg, CFU values/g (for TCBC and TCVC), respectively. Finally, the correlation between OsHV-1 load and *Vibrio* gene copies in oyster tissues was tested using Spearman\'s correlation coefficient (SPSS Statistics ver. 22.0). Significance was set at p \< 0.05 for all statistical analyses.

The relative abundance of bacterial families in each sample was graphically represented using 100% stacked 2-D column graphs (Excel, Microsoft). Diversity analyses were performed with Paleontological Statistics (PAST) software ver. 3.16 ([@bib29]). Alpha diversity was assessed by means of Shannon\'s diversity index and Simpson\'s evenness index. Dissimilarity of bacterial community structure between samples from different batches and different cohorts (beta diversity) was visualized by non-metric multidimensional scaling (n-MDS) based on the two-dimensional Bray-Curtis dissimilarity index (BC). One-way permutational multivariate analysis of variance (PERMANOVA) was used for statistical analysis of beta diversity. Significance was set at p \< 0.05 for all statistical analyses.

3. Results {#sec3}
==========

3.1. Mortality of oysters {#sec3.1}
-------------------------

The onset of mortality occurred 2 days post-OsHV-1 injection and the cumulative mortality was different for the three batches of oysters ([Fig. 1](#fig1){ref-type="fig"}, [Table 3](#tbl3){ref-type="table"}, p \< 0.05). The highest cumulative mortality was seen in the batch from Patonga Creek (63.1%) compared to oysters from Clyde River (38.1%) and Shoalhaven River (17.7%). No mortality was observed in the negative control oysters.Fig. 1Kaplan-Meier survival curves for each batch (Clyde River, Patonga Creek, Shoalhaven River) of oysters challenged with OsHV-1 (solid line) and 95% confidence intervals (dashed line). Each batch comprised n = 73--86 oysters at the onset of the viral challenge and n = 12 live oysters were sampled from each batch on days 1, 2, 3, 5, and 7. Different letters (a and b) indicate significance (p \< 0.05) identified by a mixed Cox regression model.Fig. 1Table 3Odds of mortality in oysters injected with OsHV-1 depending on the batch of oysters. (Odd\'s ratio, standard error (SE), the 95% confidence interval of the risk ratio and p-value).Table 3ContrastsOdd\'s ratioSE95% Confidence Interval (CI)p-valuePatonga vs Clyde3.000.321.61--5.54\<0.001Shoalhaven vs Clyde0.480.420.15--1.530.21Shoalhaven vs Patonga0.160.410.06--0.46\<0.001[^1]

3.2. Quantification of OsHV-1 DNA by qPCR {#sec3.2}
-----------------------------------------

The live oysters from Patonga Creek that were sampled during the infection trial had higher OsHV-1 DNA concentrations compared to their counterparts from the other two locations ([Table 4](#tbl4){ref-type="table"}; p \< 0.05). This batch also had the highest mortality and a higher OsHV-1 DNA concentration at the time of death compared to dead/moribund oysters from the Clyde River ([Table 4](#tbl4){ref-type="table"}; p \< 0.05). In all three batches, longitudinal random sampling of live oysters indicated that the quantity of OsHV-1 DNA increased on Day 2 compared to Day 1 post-injection ([Fig. 2](#fig2){ref-type="fig"}a), which coincided with the onset of mortality. All dead oysters were positive for OsHV-1 DNA and OsHV-1 DNA was not detected in oysters injected with the negative control inoculum. The quantity of OsHV-1 DNA in moribund/dead oysters was higher than in live, apparently healthy oysters sampled at random on Days 1, 2, 3, 5, and 7 post-injection ([Table 4](#tbl4){ref-type="table"}; p \< 0.001).Table 4Mean OsHV-1 concentrations in oyster tissues (geometric means and their corresponding 95% confidence intervals) during the infection.Table 4Status of oystersMean OsHV-1 concentration (OsHV-1 genome equivalents/mg)95% Confidence Interval (CI)**Live oysters:**1.61 × 10^2^8.24 × 10^1^--3.14 × 10^2^Patonga Creek1.22 × 10^3^[∗](#tbl4fnlowast){ref-type="table-fn"}2.95 × 10^2^--5.04 × 10^3^Shoalhaven River4.05 × 10^1^1.61 × 10^1^--1.02 × 10^2^Clyde River1.31 × 10^2^4.45 × 10^1^--3.88 × 10^2^**Dead oysters:**1.36 × 10^5^8.48 × 10^4^--2.20 × 10^5^Patonga Creek2.25 × 10^5^[∗](#tbl4fnlowast){ref-type="table-fn"}1.20 × 10^5^--4.22 × 10^5^Shoalhaven River5.55 × 10^4^8.15 × 10^3^--3.77 × 10^5^Clyde River9.69 × 10^4^4.75 × 10^4^--1.98 × 10^5^[^2]Fig. 2Temporal distribution of (a) OsHV-1 viral load (log~10~ OsHV-1 genome equivalents +1/mg), (b) Total bacterial load (bacterial genome equivalents/mg) and (c) Total *Vibrio* load (*Vibrio* genome equivalents/mg tissue) in live oysters that were sampled longitudinally on Days 0, 1, 2, 3, 5 and 7 post-OsHV-1 injection. All three batches showed a significant/nearly significant increase in OsHV-1 concentration on Day 2 compared to Day 1 (Patonga, p \< 0.05; Shoalhaven, p = 0.053; Clyde, p = 0.052). The Patonga oysters also showed an increase in total *Vibrio* load on Day 1 compared to Day 2 post-viral injection (p \< 0.05). All data are represented as log~10~ means ±SE.Fig. 2

3.3. Bacterial quantity {#sec3.3}
-----------------------

There was no difference in any bacteriological parameter (total bacteria load, total *Vibrio* load, TCBC and TCVC) between the three batches of oysters, at the beginning of the infection trial (p \> 0.05 for each parameter). Considering temporal dynamics during the infection, the total *Vibrio* load and TCVC in live oysters from Patonga were higher on Day 1 compared to Day 2 post-viral injection ([Fig. 2](#fig2){ref-type="fig"}c; p \< 0.05). There was no such trend in the other two batches (p \> 0.05). Overall, the highest *Vibrio* quantity was seen in oysters from Patonga during the viral infection ([Table 6](#tbl6){ref-type="table"}; p \< 0.05). The batches from Shoalhaven and Clyde Rivers demonstrated increases in the total bacterial load in live oysters on Day 2 as opposed to Day 1 post-injection ([Fig. 2](#fig2){ref-type="fig"}b; p \< 0.05). The total bacterial concentration and the total *Vibrio* concentration were higher in the tissues of dead or moribund oysters compared to apparently healthy oysters sampled on Days 1, 2, 3, 5, and 7 post-injection ([Table 6](#tbl6){ref-type="table"}; p \< 0.05). Interestingly, no change in total bacteria and total *Vibrio* was observed in the negative control oysters from all 3 batches, during the trial ([Table 5](#tbl5){ref-type="table"}; p \> 0.05).Table 6Total bacterial load and total *Vibrio* load (geometric means[†](#tbl6fndagger){ref-type="table-fn"} and their corresponding 95% confidence intervals, CI) in oysters during the viral infection.Table 6Status of oystersMean bacterial load[a](#tbl6fna){ref-type="table-fn"} (95% CI)Mean *Vibrio* load[b](#tbl6fnb){ref-type="table-fn"} (95% CI)**Live oysters:**1.08 × 10^4^ (7.89 × 10^3^--1.47 × 10^4^)4.24 × 10^1^ (3.14 × 10^1^--5.73× 10^1^)Patonga Creek2.72 × 10^4^ (1.75 × 10^4^--4.20 × 10^4^)2.88 × 10^2^ (1.91 × 10^2^--4.36 × 10^2^)\*Shoalhaven River1.48 × 10^4^ (9.17 × 10^3^--2.38 × 10^4^)1.89 × 10^1^ (1.16 × 10^1^--3.07 × 10^1^)Clyde River1.86 × 10^4^ (1.20 × 10^4^--2.89 × 10^4^)1.15 × 10^2^ (7.74 × 10^1^--1.72 × 10^2^)**Dead oysters:**9.24 × 10^4^ (5.66 × 10^4^--1.51 × 10^5^)4.19 × 10^2^ (2.69 × 10^2^--6.54 × 10^2^)[^3][^4][^5][^6]Table 5Results of Generalised Linear Model (GzLM) analysis of total bacterial load and total *Vibrio* load with the effects of geographic origin of oysters (batch), OsHV-1 challenge (treatment), days post-OsHV-1 injection (day) and outcome of infection (status) accounted for in the model.Table 5Total bacterial loadTotal *Vibrio* loaddfX^2^p-valuedfX^2^p-valueIntercept12609.97\<0.0011644.97\<0.001Batch21.050.593252.69\<0.001Treatment11.850.17412.400.121Day628.61\<0.001619.390.004Status130.78\<0.001136.41\<0.001Batch × Group × Day × Status28108.62\<0.00124118.97\<0.001[^7]

Although changes were noted with the *Vibrio* load in oysters challenged with OsHV-1, the average relative percentage of *Vibrio* spp. from the total bacterial population, remained low with 0.26% in pre-challenged oysters and reaching a maximum of 5.25% on Day 1 post-injection. Overall, a strong correlation was observed between the OsHV-1 DNA load and the total *Vibrio* load in OsHV-1 infected oyster tissues (r = 0.6; p \< 0.001). Representative *Vibrio* isolates from the OsHV-1 infected oysters were identified as *Vibrio alginolyticus* (3/6) and *Vibrio mediterranei* (2/6), by biochemical methods.

3.4. Bacterial community structure in different batches of oysters {#sec3.4}
------------------------------------------------------------------

Both Shannon\'s diversity index (H) and Simpson\'s evenness index (S) were different between the oysters grown in the three different estuaries, before acclimation to the laboratory conditions and OsHV-1 challenge (p \< 0.05). Both H and S were highest in oysters from Patonga Creek (H = 1.77, S= 0.74) compared to those from the Clyde River (H = 0.77, S = 0.33) and Shoalhaven River (H = 1.14, S = 0.54). While the relative abundance of family *Brachyspiraceae* was quite low (0.8%) in the batch from Patonga Creek, a comparatively higher relative abundance was seen in the other two batches (Shoalhaven, 24.3%; Clyde 10.3%; [Fig. 3](#fig3){ref-type="fig"}). In contrast, the relative abundance of family *Moraxellaceae* was higher in oysters from Patonga Creek (13.5%) compared to the other two batches (Shoalhaven, 2.9%; Clyde 1.7%). Further, the relative abundance of family *Deinococcaceae* was observed to be 16.1 % in the oysters from Patonga Creek while it was negligible in the other two batches ([Fig. 3](#fig3){ref-type="fig"}).Fig. 3Relative abundance of bacterial families in oysters farmed in different estuaries: before OsHV-1 challenge (A); apparently healthy oysters 24h after OsHV-1 challenge (B); challenged oysters at or near death (C); surviving oysters at the completion of a 7-day OsHV-1 challenge period (D); unchallenged control oysters at the end of the trial period (E). Patonga, oysters from Patonga Creek; Shoalhaven, oysters from Shoalhaven River; Clyde, oysters from Clyde River. The bacterial families that constituted \>5% of an individual sample and were found in at least two samples are presented, and the rest are indicated as 'others'.Fig. 3

3.5. Changes in bacterial community during OsHV-1 infection {#sec3.5}
-----------------------------------------------------------

The relative abundance of bacterial families changed in all three batches of oysters, 24 h post-OsHV-1 injection. However, the direction of changes was different between batches. For example, the relative percentage of family *Brachyspiraceae* increased up to 60.4 % in Patonga oysters while it decreased to 3.2% and 2.4% in oysters from Shoalhaven and Clyde Rivers, respectively (see section [3.4](#sec3.4){ref-type="sec"} for initial values; [Fig. 3](#fig3){ref-type="fig"}). Moreover, the family *Hyphomicrobiaceae* which was either absent or present in negligible amounts in the pre-challenge oysters was seen to increase in oysters from Shoalhaven River (2.1%) and Clyde River (18.1%). This was not observed in Patonga oysters. During the OsHV-1 infection, the dead/moribund oysters from Patonga Creek showed a decrease in bacterial diversity (H = 1.66, S = 0.68) compared to pre-challenge (H = 1.77, S = 0.74; p \< 0.05). However, the dead or moribund oysters from the other two locations, with an originally lower diversity, did not demonstrate such a decrease (p \> 0.05). Furthermore, the bacterial community structure in Patonga and Shoalhaven oysters that survived the OsHV-1 challenge at the end of the 7-day trial, were similar to their counterparts in the pre-challenged cohort ([Fig. 4](#fig4){ref-type="fig"}, p \> 0.05). Moreover, the bacterial community structure in Patonga and Clyde oysters that were challenged with the negative control, were not different from the pre-challenge counterparts, at the end of 7 days in the laboratory.Fig. 4Non-metric multidimensional scaling based on two-dimensional Bray-Curtis dissimilarity. Colours indicate different cohorts: black (A), before OsHV-1 challenge; green (B), 24h after viral challenge; red (C), dead/moribund oysters; blue (D), survived oysters; yellow (E), control oysters at the end of the experiment. Shapes indicate different locations of origin of the oysters: circle, Patonga Creek; square, Shoalhaven River; star, Clyde River.Fig. 4

4. Discussion {#sec4}
=============

The present study discusses how the bacterial community composition of Pacific oysters with a common hatchery origin can be influenced by the geographic site at which they are grown. It also discusses how these influences are related to the changes in the Pacific oyster microbiome and OsHV-1 load during an experimental OsHV-1 infection conducted in a controlled environment. Further, the study the provides insights as to how these differences in microbiome composition affect the outcome of the OsHV-1 infection, in addition to the impact of age factor.

Our results showed that the bacterial community composition of the Pacific oyster microbiome was different between the oysters grown in the three geographically distinct estuaries despite their common hatchery origin. The filter-feeding pattern of oysters leading to the uptake of environmental microbes with their feed can be attributed to these differences in microbiomes of oysters with a common genetic origin. The study involved three batches of oysters from two broad age categories (juvenile oysters (n = 1) and adult (n = 2). The adult batches were of approximately equal ages (14 and 16 months). In addition to the difference of age between the juveniles and adults, we also observed a difference between the microbiome composition of the two batches of adult oysters, indicating an influence of farming environment in shaping the microbiome composition. Further studies are required to focus on controlling other factors such as age to further evaluate the influence of environment on the microbiome. A metagenomic study in *Crassostrea virginica* revealed differences in microbiomes in oysters reared in different sites ([@bib59]) while conventional bacterial studies conducted using *C. virginica* have also shown that the bacterial composition in oysters varies with their environment ([@bib70]). However, it is also important to note that the microbiome composition is also influenced by host-related factors as well as by interactions within the microbiome, in the long run ([@bib51]).

In the present study, we observed changes in the oyster microbiome soon after the viral challenge. These changes may primarily reflect the initial response of the microbiome to the viral infection. Having said that, it is interesting to note that the microbiome of Patonga oysters behaved differently to the other two batches along with a higher OsHV-1 DNA concentration in tissues and higher mortality. The difference in the mortality pattern was consistent with previous studies ([@bib73]; [@bib93]; [@bib33]) whereby juvenile oysters (\<1 year) had higher mortality than adult oysters (\>1 year). However, it was interesting to note that there was no difference in mortality between the two batches of adults despite a higher concentration of OsHV-1 in Clyde oysters which can be corresponded to differences noted in the initial microbiome composition. Moreover, the oysters from Patonga Creek demonstrated the highest initial bacterial diversity and showed a decrease in bacterial diversity during the moribund stage. This was not seen with the other two batches, indicating a differential response of the microbiome. In a study conducted by [@bib91], Pacific oysters with initially high microbial diversity had shown a decrease in diversity following disturbance due to heat stress, whereas oysters with originally lower diversity did not show such a decrease after exposure to heat. Low bacterial diversity has repeatedly been found with impaired health in oysters ([@bib25]; [@bib28]). Thus, the decrease in bacterial diversity which precedes mortality can be considered a good indicator in declining health in oysters ([@bib91]; [@bib49]). Furthermore, studies involving pathogenic *Vibrio* infections in Pacific oysters have shown bacterial community structure disruption in dead/moribund oysters, characterized by very low diversity ([@bib49]).

The changes in the microbiome that were observed in oysters challenged with the virus, were not seen in the control oysters from two batches, in our study. The bacterial community composition of those control oysters was not different from their pre-challenged counterparts, at the end of 7 days in the laboratory. As the control oysters were also subjected to muscle relaxation and was given an injection, the disturbance to the microbiome prior to the viral challenge, appear to be transient. In contrast, the changes induced by OsHV-1 infection seem to remain and can be considered as an indication of a disease state. Oyster families susceptible to OsHV-1 showed disruption of the bacterial community structure when cohabitated with OsHV-1-injected oysters ([@bib12]).

Despite the inter-batch differences observed in bacterial community composition after 24 h of the viral challenge, the total bacterial load remained same. The persistent bacterial community composition at higher taxonomic levels regardless of the changes in lower taxonomic levels ([@bib50]) can be attributed to this static bacterial load. In the present study, the Patonga oysters displayed the highest total *Vibrio* load with a peak on Day 1 post-injection. This peak may be associated with the higher and early (on Day 2 post-injection) mortality in Patonga oysters which was not seen in oysters from the other two batches. While the Shoalhaven oysters reported few mortalities, no mortalities were observed in Clyde oysters as early as Day 2 post-injection. Although we could not test the pathogenicity of the *Vibrio* isolates of our study, it is possible that this increase in *Vibrio*, to have a role in the final cumulative mortality. Stress-related shifts in the oyster microbiome resulting in increase in the potentially pathogenic bacteria are thought to contribute to oyster mortality ([@bib49]).

Although differences in temporal *Vibrio* dynamics and the total *Vibrio* load were noted between batches, we observed a low average relative abundance of *Vibrio* spp. in all batches, throughout the course of the viral infection. This was consistent with previous studies reporting oyster mortality events in the field ([@bib37]) as well as experimental conditions ([@bib49]). [@bib89] also reports a very low abundance of *Vibrio* in gut tissues obtained from healthy Pacific oysters. Contrary to the conventional knowledge that identifies *Vibrio* spp. as one of the dominating bacterial genera in oysters ([@bib8]; [@bib70]), a large proportion of the oyster microbiome cannot be cultivated by standard procedures ([@bib76]; [@bib20]). Previous literature on Eastern oysters (*C. virginica)* and Sydney rock oysters (*Saccostrea glomerata*) also report low relative abundances of *Vibrio* spp. ([@bib28]; [@bib59]). Nevertheless, *Vibrio* spp. can have an impact on the host health, despite its low relative abundance ([@bib87]).

We also observed a wider range of OsHV-1 DNA concentrations (10^2^ - 10^6^ viral copies/mg oyster tissue) in oysters that died during this infection trial. Previous field and lab studies have demonstrated viral concentrations exceeding 10^6^-10^7^ copies mg/tissue to be associated with moribund/dead oysters infected with OsHV-1 ([@bib64]; [@bib58]; [@bib62]). As highlighted by [@bib61], variations in the OsHV-1 DNA concentration in moribund oyster tissues can be expected due to various reasons such as genetic background, age, physiology and life history. Despite the highest OsHV-1 DNA concentration in the youngest batch (10 months), the lowest OsHV-1 concentration was not reported from the oldest batch (16 months) but a younger batch (14 months), in this study. This indicated a potential role of factors other than age in determining the physiological response of oysters to OsHV-1. Apart from the role played by age in OsHV-1 infections ([@bib60]; [@bib33]), the differences in the microbiome composition among the batches may have differentially influenced the viral multiplication in these organisms. Recent studies on OsHV-1 disease have highlighted the role of size and other factors such as life history and genetics, on oyster mortality ([@bib68]; [@bib2], [@bib3]). Interactions between the age and size of oysters in determining the susceptibility of Pacific oysters to OsHV-1-related mortality ([@bib33]) suggest complex interactions of a range of factors other than age, in causing mortality.

There was a strong correlation between the OsHV-1 DNA load and *Vibrio* load in infected oysters, in the present study. Conventional culture methods used in *Vibrio* quantification have not seen such a correlation between the *Vibrio* concentration and the OsHV-1 DNA load in oysters exposed to a field mortality outbreak ([@bib69]). [@bib46] have shown that the non-virulent strains of *Vibrio* spp. inhabiting healthy oysters get progressively replaced by phylogenetically coherent, virulent strains of *Vibrio* during the onset of a natural infection. These non-virulent strains are also expected to facilitate the disease caused by the virulent strains. Thus, the difference in correlation of *Vibrio* gene copy number and cultivable *Vibrio* load, to OsHV-1 DNA load and can be attributed to the ability of the PCR assay in detecting non-cultivable *Vibrio* strains ([@bib6]), or the non-virulent strains of *Vibrio* that were dead and were replaced by pathogenic *Vibrio* strains.

The apparently healthy oysters used in our study were injected with a bacteria-free, partially purified tissue homogenate carrying OsHV-1 and were maintained in artificial seawater throughout the experimental period. Therefore, all *Vibrio* strains quantified and isolated in this study should originate from the oyster microbiome. *Vibrio alginolyticus* that was isolated in our study have been previously reported in mass mortality events of Pacific oysters ([@bib27]). As mentioned above, we could not test the pathogenicity of the *Vibrio* isolates of our study nor could we identify the same species with 16S rRNA metabarcoding as the genetic resolution did not permit identification of *Vibrio* at species level. Testing the pathogenicity of *Vibrio* isolates may have provided valuable clues to identify the pathogenic role of *Vibrio* spp. present in the Pacific oyster microbiome, during OsHV-1 infections. In an experiment where oysters exposed to a field mortality outbreak and subsequently treated with chloramphenicol, [@bib69] demonstrated that a high load of OsHV-1 DNA (≥10^8^ viral copies/mg tissue) is not sufficient for a full expression of the disease by demonstrating a delayed and reduced oyster mortality in the absence of bacteria. In this regard, the indication that the pathogenic species or strains of *Vibrio* in healthy oysters become pathogenic when there is a primary viral infection, needs to be studied further. Moreover, it is important to investigate whether the mass mortality events reported among Pacific oysters are caused by several different infectious diseases or by a single polymicrobial disease, by targeting *Vibrio* spp. alone.

5. Conclusion {#sec5}
=============

The composition of the bacterial community in Pacific oysters grown in different geographic sites was different despite their common hatchery origin. In addition to the differences related to age, different outcomes of OsHV-1 challenge were seen between same-aged batches, with differences in the initial microbiome. The initial bacterial community composition did not change in some batches of oysters that survived OsHV-1 challenge and in oysters challenged with the negative control. The higher *Vibrio* load in oysters with higher OsHV-1 DNA content and higher mortality suggests a role of *Vibrio* in mortality associated with OsHV-1 infections. Further studies are needed to evaluate the direct and indirect influences of *Vibrio* and other members of the resident microbial community of oysters during OsHV-1 infection.
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[^1]: Patonga, Patonga Creek; Shoalhaven, Shoalhaven River; Clyde, Clyde River.

[^2]: OsHV-1 concentration in live Patonga oysters was higher than the other two batches. It was also higher in dead Patonga oysters compared to dead oysters from Clyde River.

[^3]: \*The mean *Vibrio* load in Patonga oysters were higher than in the other two batches (p \< 0.05).

[^4]: Bacterial genome equivalents/mg.

[^5]: *Vibrio* genome equivalents/mg.

[^6]: Geometric means were derived from back-transformed model means.

[^7]: Note: df, degree of freedom; X^2^, Wald Chi Square.
